MediWound Expands NexoBrid’s Global Presence with Marketing Approval in Japan
Japan is the first country in the world to approve NexoBrid for people of all…
News
CytoDyn to Hold Webcast to Discuss the Performance of Leronlimab in Clinical Trials and Recent Charges Against Former CEO
VANCOUVER, Washington, Dec. 23, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the…
Immutep Announces Successful Meeting with the FDA on Eftilagimod Alpha plus Chemotherapy for the Treatment of Metastatic Breast Cancer
Agreement with FDA on Phase II/III trial design positions the Company to exploit eftilagimod alpha’s…
Intercept Resubmits New Drug Application to U.S. FDA for Obeticholic Acid in Patients with Liver Fibrosis due to NASH
NDA supported by robust NASH clinical development program, including two positive interim analyses from the…
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1 Trial of KUR-101
– This two-part phase 1 trial in healthy volunteers was designed to assess the safety,…
Bee Vectoring Technologies Announces Addition of Ashish Malik to its Board of Directors
Mississauga, Ontario and Sacramento, California–(Newsfile Corp. – December 23, 2022) – Bee Vectoring Technologies International…
FansUnite Provides Corporate Update
Vancouver, British Columbia–(Newsfile Corp. – December 23, 2022) – FansUnite Entertainment Inc. (TSX: FANS) (OTCQX:…
Primergy Solar Secures up to $200M Revolving Credit Facility from Rabobank
Funding supports expanded in ERCOT, MISO, PJM and WECC making Primergy’s project portfolio exceed 14…
CMCT Announces Redemption in Full of Series L Preferred Stock
DALLAS–(BUSINESS WIRE)–Creative Media & Community Trust Corporation (NASDAQ: CMCT and TASE: CMCT-L) announced today that,…
Outlook Therapeutics Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
ISELIN, N.J., Dec. 23, 2022 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical…
Nykode Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
OSLO, Norway, Dec. 23, 2022 (GLOBE NEWSWIRE) — Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage…
FREYR Battery Appoints Executive to Lead Global Corporate Development and U.S. Execution
NEW YORK & OSLO & LUXEMBOURG–(BUSINESS WIRE)–FREYR Battery (NYSE: FREY) (“FREYR” or “the Company”), a…
United States Used Car Market Outlook Report 2022-2026 – Driven by An Influx of Digital Players Along With Consumer Demand for Personal Mobility and Affordable Pricing – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “USA Used Car Market Outlook to 2026 – Driven by An Influx of…
BioNTech Initiates Phase 1 Clinical Trial for Malaria Vaccine Program BNT165
BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention based on a novel…
Bavarian Nordic Enters Agreement Valued up to USD 83 Million with the U.S. Department of Defense to Further Advance the Development of Equine Encephalitis Virus Vaccine
Total considerations of up to USD 83 million with the majority secured for Phase 2…
DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on VITESSE Phase 3 Pivotal Trial
Montrouge, France, December 23, 2022 DBV Technologies Announces FDA Has Lifted Partial Clinical Hold on…
Basilea announces regulatory approval of antifungal Cresemba® (isavuconazole) in Japan
Japanese regulatory authority granted marketing authorization to Basilea’s license partner, Asahi Kasei Pharma Intravenous and…
Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate
Saint-Herblain (France), December 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty…
LBank Exchange Will List DiDimCoin (DDC) on December 23, 2022
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…
FLAG Token (FLAG) Is Now Available for Trading on LBank Exchange
Internet City, Dubai–(Newsfile Corp. – December 23, 2022) – LBank Exchange, a global digital asset…